In adult trials, nausea was reported in 44 percent of Wegovy-treated patients versus 16 percent on placebo, diarrhea in 30 versus 16 percent, vomiting in 24 versus 6 percent, constipation in 24 versus 11 percent, abdominal pain in 20 versus 10 percent, and headache in 14 versus 10 percent
The delivery method may offer convenience benefits, but it does not transform a supplement into something with pharmaceutical-level effects
However, prior authorization might be necessary
Onset, Peak, and Duration Most people observe a gradual onset within a few hours, with effects continuing for about a day
These modifications enhance its half-life by increasing albumin binding and inhibiting degradation by DPP-4, allowing for once-weekly dosing
GLP-1s are a prime example